Pilot study suggests new approach to treat preeclampsia

A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition -- balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.

Read the whole article on Science Daily

More from Science Daily